| Patents for C12N 7 - Viruses, e.g. bacteriophages; Compositions thereof; Preparation or purification thereof (26,637) |
|---|
| 10/30/2001 | CA2227308C Dna sequence coding for a polypeptide which enhances virus infection of host insects |
| 10/25/2001 | WO2001079542A2 Hiv detection assay and reagents therefor |
| 10/25/2001 | WO2001079518A2 Codon optimisation for expression in retrovirus packaging cells |
| 10/25/2001 | WO2001079456A2 Materials and methods relating to increasing viral titre |
| 10/25/2001 | WO2001079273A2 Viruses comprising mutated ion channel protein |
| 10/25/2001 | WO2001078792A1 Method of inactivating pathogens |
| 10/25/2001 | WO2001078776A1 Herpes virus complementing cell line |
| 10/25/2001 | WO2001078770A1 Inhibition of transmission of tick-borne infections |
| 10/25/2001 | WO2001023597A3 Cell lines and constructs useful in production of e1-deleted adenoviruses in absence of replication competent adenovirus |
| 10/25/2001 | US20010034055 Passing a sample through a membrane grafted with a polymer having functional groups interactive with the viruses and with a pore size of 20-1000nm; cleaning blood of infection gene therapy; genetic engineerng; nonremoval of proteins |
| 10/25/2001 | US20010034054 Producing replication-defective adeno-associated virons(AAV) free of wild-type AAV and helper adenovirus by introducing into a host cell an AAV vector, an AAV helper construct and an adenoplasmid accessory construct; unpackageable; lysis |
| 10/25/2001 | US20010034022 Providing a sample suspected of containing enterovirus and a mixed cell culture comprising Rhabdomyosarcoma cells and human mucoepidermoid cells, inoculating mixed cell culture with sample, observing inoculated culture for enterovirus |
| 10/25/2001 | US20010034019 Chimeric HCV/GBV-B viruses |
| 10/25/2001 | US20010034018 Contacting a sample with an antibody which binds to SVI (Sentinel virus 1) or a protein and the antibody does not bind TTV strains SANBAN and TUS01 or protiens and detecting the complexes of antibody and SVI virus or protein |
| 10/25/2001 | CA2406283A1 Materials and methods relating to increasing viral titre |
| 10/25/2001 | CA2406180A1 Viruses comprising mutant ion channel protein |
| 10/25/2001 | CA2404129A1 Codon optimisation for expression in retrovirus packaging cells |
| 10/24/2001 | EP1147227A1 Lipophilic quenching of viral inactivating agents |
| 10/24/2001 | EP1147181A2 Telomerase reverse transcriptase transcriptional regulatory sequences |
| 10/24/2001 | EP1147180A1 Propagation of bovine coronavirus in chinese hamster ovary cells |
| 10/24/2001 | EP1147128A1 Binding molecules for human factor viii and factor viii-like proteins |
| 10/24/2001 | EP0910405B1 Vaccine containing caprine arthritis-encephalitis virus and use for immunoprotection against hiv-1 infection |
| 10/24/2001 | CN1319140A Recombinant CELO virus and CELO virus DNA |
| 10/24/2001 | CN1319139A Polynucleotide constructs and uses thereof |
| 10/24/2001 | CN1318646A Coded salmonella typhi specific and antigenic outer membrane protein DNA sequence |
| 10/23/2001 | USRE37416 Method for manufacturing a modular semiconductor power device |
| 10/23/2001 | US6306652 Packaging systems for human recombinant adenovirus to be used in gene therapy |
| 10/23/2001 | US6306582 Mixed cell diagnostic systems |
| 10/23/2001 | US6306581 Diagnostic assay method and kit for the detection of HHV-8 infection |
| 10/23/2001 | US6306401 Genetically-engineered sindbis virus with modified E2 Glycoprotein and altered host-range phenotype |
| 10/23/2001 | US6306400 For immunization of chickens |
| 10/23/2001 | CA1341308C Vaccines against avian herpes viruses |
| 10/23/2001 | CA1341307C Nucleotide sequences of avian herpes viruses |
| 10/19/2001 | CA2304123A1 Antibacterial therapy for multi-drug resistant bacteria |
| 10/18/2001 | WO2001077358A2 Herpes viruses for immune modulation |
| 10/18/2001 | WO2001077304A1 Method of producing adenoviral vector stocks |
| 10/18/2001 | WO2001077157A2 FULL-LENGTH gb virus c (HEPATITIS G VIRUS) RNA TRANSCRIPTS ARE INFECTIOUS IN PRIMARY CD4 POSITIVE T CELLS AND METHODS OF TREATING HIV |
| 10/18/2001 | WO2001076624A1 Inactivated japanese b encephalitis vaccine and process for producing the same |
| 10/18/2001 | WO2001045737A3 Herpes simplex virus-1 glycoprotein c mutants for treating unwanted hyperproliferative cell growth |
| 10/18/2001 | WO2001038548A3 Vectors capable of immortalizing non-dividing cells and cells immortalized with said vectors |
| 10/18/2001 | WO2000020041A9 Removal of preexisting antibodies to enhance the effectiveness of a therapeutic viral immunogenic agent |
| 10/18/2001 | US20010031463 Using an antibody linked to an activated chromatographic material, applying a sample containing Adeno-associated type 2 viruses (AAV-2), and eluting with a solution containing magnesium chloride |
| 10/18/2001 | CA2400746A1 Method of producing adenoviral vector stocks |
| 10/17/2001 | EP1146125A1 Poxvirus with targeted infection specificity |
| 10/17/2001 | EP1145010A1 Purification process using magnetic particles |
| 10/17/2001 | EP1144667A2 Retroviral expression vectors on the basis of herv- long terminal repeat sequences |
| 10/17/2001 | EP1144607A2 Methods for displaying (poly)peptides/proteins on bacteriophage particles via disulfide bonds |
| 10/17/2001 | EP1144600A2 Akt-3 nucleic acids, polypeptides, and uses thereof |
| 10/17/2001 | EP1144420A1 Sulfated phosphatidylinositols, their preparation and use |
| 10/17/2001 | EP1144005A1 Treatment of papillomavirus infections |
| 10/17/2001 | CN1318104A HIV vaccine |
| 10/16/2001 | US6303779 Process for isolating and purifying viruses and sugars from plant sources |
| 10/16/2001 | US6303768 Methuselah gene, compositions and methods of use |
| 10/16/2001 | US6303371 Method of purified rAAV vector production in non-human cell line transfected with cocksackie and adenovirus receptor |
| 10/16/2001 | US6303344 Methods and compositions for polypeptide engineering |
| 10/16/2001 | US6303334 Nucleotide sequences coding polypeptides for use in as a viricide and in gene therapy |
| 10/16/2001 | CA2031164C Recombinant herpesvirus of turkeys and live vector vaccines derived thereof |
| 10/11/2001 | WO2001075147A1 Method of concentrating and recovering a viral enzyme activity from biological samples |
| 10/11/2001 | WO2001075097A2 Improvements to ribosome display |
| 10/11/2001 | WO2001074849A2 Binding peptides for carcinoembryonic antigen (cea) |
| 10/11/2001 | WO2001074386A2 Cold-adapted equine influenza viruses |
| 10/11/2001 | WO2001032702A9 Molecular structure of rhd negative locus |
| 10/11/2001 | WO2001021807A8 Hepatitis c virus envelope two protein (e2) which lacks all or part of the hypervariable region one (hvr1), corresponding nucleic acids, chimeric viruses and uses thereof |
| 10/11/2001 | WO2000057908A9 Attenuated dengue-1 virus vaccine |
| 10/11/2001 | US20010029249 Adenovirus comprising a gene coding for glutathione peroxidase |
| 10/11/2001 | US20010029041 Isolated, live, attenuated phenotype useful for stimulating protective immune response without producing severe symptoms; respiratory stress |
| 10/11/2001 | DE19964162A1 Verfahren zur Abtötung, Abschwächung und Veränderung von Bakterien, Bakteriophagen, Viren, Virophagen, Prionen und Pilzen mit hohen Drücken Method of killing, mitigation and change of bacteria, bacteriophages, viruses, Virophage, prions and fungi with high pressures |
| 10/11/2001 | CA2403979A1 Cold-adapted equine influenza viruses |
| 10/11/2001 | CA2403242A1 Binding peptides for carcinoembryonic antigen (cea) |
| 10/11/2001 | CA2402452A1 Improvements to ribosome display |
| 10/10/2001 | EP1142473A1 Method of acquiring immunological tolerance |
| 10/10/2001 | EP1141721A1 Conjugates for detecting viruses that cause diseases of the respiratory tract and use thereof |
| 10/10/2001 | EP1141357A1 Adenovirus vectors, packaging cell lines, compositions, and methods for preparation and use |
| 10/10/2001 | EP1141342A2 Use of plus-strand synthesis elements in retroviral vectors |
| 10/10/2001 | EP1141338A1 Recombinant herpes simplex virus useful for treating neoplastic disease |
| 10/10/2001 | EP1141315A2 Modified hiv env polypeptides |
| 10/10/2001 | EP1141314A2 Polynucleotides encoding antigenic hiv type c polypeptides, polypeptides and uses thereof |
| 10/10/2001 | EP1141313A2 Improved expression of hiv polypeptides and production of virus-like particles |
| 10/10/2001 | EP1141296A2 Interferon-epsilon |
| 10/10/2001 | EP1141250A2 Intein-mediated cyclization of peptides |
| 10/10/2001 | EP1141249A1 Method for separating viral particles |
| 10/10/2001 | EP1140989A1 Alpha(v) beta(6) integrin inhibitors |
| 10/10/2001 | EP1140974A1 Neutralizing assay using human papillomavirus virus-like particles |
| 10/10/2001 | EP1140164A2 Multivalent immunogenic composition containing rsv subunit composition and influenza virus preparation |
| 10/10/2001 | EP1140161A1 Synthetic virus-like particles with heterologous epitopes |
| 10/10/2001 | EP0804233B1 Methods for the cultivation of infectious laryngotracheitis virus and egg drop syndrome virus |
| 10/10/2001 | EP0672157B1 Recombinant viruses comprising artificial proteolytic cleavage site |
| 10/09/2001 | US6300490 Expression vector coding cytosine deaminase; for use in the treatment of cancers |
| 10/09/2001 | US6300120 Phage with nuclear localization signal |
| 10/09/2001 | US6300118 Plasmids comprising a genetically altered feline immunodeficiency virus genome |
| 10/09/2001 | US6300090 Delivering antigens to proliferating and non-proliferating dendritic cells using a nonreplicating influenza viral vector; the dentritic cells will process and express the antigen which will then activate cd8 cytotoxic t lymphocytes |
| 10/09/2001 | US6300061 Screening drug susceptibilities of mycobacterial lysogens by using a luciferase reporter mycobacteriophage incubated with clinical samples, expressing the reporter gene if the sample contains the mycobacteria, diagnosing mycobacterial infection |
| 10/09/2001 | US6299882 UL54.5 of Marek's disease virus (MDV) |
| 10/04/2001 | WO2001073093A2 Cell-specific adenovirus vectors comprising an internal ribosome entry site |
| 10/04/2001 | WO2001072994A2 Human urothelial cell specific uroplakin transcriptional regulatory sequences, vectors comprising the same, and methods of use thereof |
| 10/04/2001 | WO2001072340A1 Aids virus vaccine with the use of sendai virus vector |
| 10/04/2001 | WO2001018058A3 Enhanced phage display library of human vh fragments and methods for producing same |
| 10/04/2001 | WO2000046355A9 Telomerase reverse transcriptase transcriptional regulatory sequences |
| 10/04/2001 | US20010026938 Containing DNA expressing the adenovirus protease; for gene transfer purposes, vaccines |
| 10/04/2001 | US20010026799 Genome with mutation expresses native immediate early gene from genome with delayed kinetics; gene therapy |